The impact of social vulnerability on primary vaccine coverage in children with sickle cell disease

社会脆弱性对镰状细胞病患儿初次疫苗接种覆盖率的影响

阅读:2

Abstract

INTRODUCTION: This study examines the relationship between social vulnerability and up-to-date (UTD) primary vaccine coverage among children with sickle cell disease (SCD). METHODS: This retrospective cohort study included children with SCD born in Georgia between 2008 and 2019, identified through the state newborn screening program. Immunization records were obtained from the state registry, and birth addresses were matched to census tract level Social Vulnerability Index (SVI) scores. Children were considered UTD if they completed the recommended vaccine doses by 24 months. Multivariable logistic regression assessed the association between overall and subtheme SVI scores and vaccine completion, adjusting for demographic and clinical covariates. RESULTS: The study included 1,337 children with SCD. Of these, 37% lived in areas with the highest SVI vulnerability, and 12% lived in the least vulnerable areas. Overall, 58% of children were UTD with their primary vaccine series. Children with moderate or high vulnerability in the socioeconomic subtheme had significantly higher odds of having UTD poliovirus vaccine, measles, mumps, and rubella vaccine, haemophilus influenzae type-b vaccine, and hepatitis B vaccine compared to children with low vulnerability. Higher vulnerability in the housing type and transportation marginally decreased the odds of completing the diphtheria, tetanus, and acellular pertussis vaccine. DISCUSSION: Children with SCD are disproportionately concentrated in areas of high social vulnerability. The SVI can help identify neighborhoods for targeted vaccine outreach, especially in communities with high housing and transportation vulnerability. Efforts should prioritize multi-dose vaccines and the varicella vaccine.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。